OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 76 filers reported holding OCULAR THERAPEUTIX INC in Q1 2017. The put-call ratio across all filers is 0.60 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $36,303,300 | -40.0% | 5,307,500 | -20.2% | 8.30% | -37.1% |
Q1 2024 | $60,543,556 | +123.6% | 6,653,138 | +9.6% | 13.19% | +83.3% |
Q4 2023 | $27,072,200 | +33.3% | 6,070,000 | -6.2% | 7.20% | +9.0% |
Q3 2023 | $20,309,520 | -31.9% | 6,468,000 | +11.9% | 6.61% | -7.4% |
Q2 2023 | $29,824,800 | -7.3% | 5,780,000 | -5.3% | 7.13% | -26.0% |
Q1 2023 | $32,178,093 | +88.5% | 6,105,900 | +0.5% | 9.64% | +62.4% |
Q4 2022 | $17,070,750 | -36.4% | 6,075,000 | -6.0% | 5.94% | -46.4% |
Q3 2022 | $26,830,000 | +11.7% | 6,465,000 | +8.2% | 11.08% | +2.4% |
Q2 2022 | $24,019,000 | -18.8% | 5,974,800 | 0.0% | 10.83% | +17.9% |
Q1 2022 | $29,575,000 | -29.0% | 5,974,800 | 0.0% | 9.18% | +4.0% |
Q4 2021 | $41,644,000 | -35.7% | 5,974,800 | -7.8% | 8.83% | -27.0% |
Q3 2021 | $64,800,000 | -29.5% | 6,480,000 | 0.0% | 12.10% | -20.7% |
Q2 2021 | $91,886,000 | -13.6% | 6,480,000 | 0.0% | 15.26% | -2.3% |
Q1 2021 | $106,337,000 | -21.1% | 6,480,000 | -0.5% | 15.62% | -11.3% |
Q4 2020 | $134,758,000 | +195.9% | 6,510,000 | +8.8% | 17.60% | +97.6% |
Q3 2020 | $45,540,000 | -8.6% | 5,984,200 | 0.0% | 8.91% | -11.5% |
Q2 2020 | $49,848,000 | +96.6% | 5,984,200 | +16.8% | 10.07% | +49.8% |
Q1 2020 | $25,356,000 | +25.7% | 5,122,500 | +0.3% | 6.72% | +69.7% |
Q4 2019 | $20,175,000 | +139.2% | 5,107,500 | +84.1% | 3.96% | +29.8% |
Q3 2019 | $8,436,000 | -35.0% | 2,775,000 | -5.9% | 3.05% | -22.9% |
Q2 2019 | $12,980,000 | +72.1% | 2,950,000 | +55.3% | 3.96% | +89.4% |
Q1 2019 | $7,543,000 | +37.0% | 1,900,000 | +137.5% | 2.09% | +49.2% |
Q3 2018 | $5,504,000 | -26.6% | 800,000 | -28.0% | 1.40% | -27.9% |
Q2 2018 | $7,499,000 | +46.9% | 1,111,000 | +102.0% | 1.94% | -23.6% |
Q1 2017 | $5,104,000 | +551.9% | 550,000 | +487.6% | 2.54% | +451.0% |
Q4 2016 | $783,000 | -39.2% | 93,600 | -64.0% | 0.46% | -46.4% |
Q2 2016 | $1,287,000 | – | 260,000 | – | 0.86% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SUMMER ROAD LLC | 5,618,861 | $79,675,000 | 100.00% |
Opaleye Management Inc. | 6,480,000 | $91,886,000 | 15.26% |
DELTEC ASSET MANAGEMENT LLC | 2,167,313 | $30,732,000 | 4.23% |
Kamunting Street Capital Management, L.P. | 624,201 | $8,851,000 | 3.58% |
GREAT POINT PARTNERS LLC | 919,887 | $13,044,000 | 2.74% |
Endurant Capital Management LP | 570,970 | $8,096,000 | 2.22% |
Rubric Capital Management LP | 2,156,542 | $30,580,000 | 1.92% |
Affinity Asset Advisors, LLC | 250,000 | $3,545,000 | 1.27% |
Altium Capital Management LP | 256,152 | $3,632,000 | 0.84% |
Ikarian Capital, LLC | 700,000 | $9,928,000 | 0.80% |